Takaisin kaikkiin työpaikkoihin

Doctoral Researcher in Molecular Biology of Transcription

Helsingin yliopisto · Helsinki

Lisää työpaikkoja: Helsingin yliopisto (45) →
Paikan päälläentry💰 2 470–2 470 EURKoulutus · TutkimusJulkaistu 20.11.2026 klo 02.00

Taidot

bioinformaticsmolecular biologyLinuxcommand-line toolscell culturerna biologychip-sequencingrna-sequencing

Työn kuvaus

Tiivistelmä työpaikkailmoituksesta: Doctoral Researcher position in Dr Harri M. Itkonen’s group to study transcriptional rewiring in prostate cancer and develop novel therapies. Applicants must hold or soon obtain an MSc and have competence in bioinformatics and/or molecular biology, command-line Linux skills, strong English, and experience in cell culture, RNA biology or ChIP-/RNA-sequencing. The fixed-term position starts in spring 2027 for two years with a six-month trial period and offers a salary of about 2,470 euros per month. Applications must be submitted via the University of Helsinki recruitment system with a cover letter, CV, references, transcripts and diplomas by 27 December 2026. Tämä tiivistelmä on luotu tekoälyn avulla. Dr Harri M. Itkonen’s research group at the Faculty of Medicine, University of Helsinki, invites applications for the position of DOCTORAL RESEARCHER (PhD Trainee) We are looking for a creative thinker with demonstrated competence in bioinformatics, who has high motivation to develop novel therapies to treat cancer. The applicant should be familiar with command-line based tools used in Linux. Of equal importance is the candidate’s willingness to either already possess, or, alternatively, willingness, to learn molecular biology. Alternatively, applications from MSc-graduates with excellent skills in molecular biology are also invited. Our research We study the rewiring of transcriptional networks in cancer cells, and how this rewiring could be exploited as a basis for cancer therapy. The major disease model of interest is prostate cancer, and particularly the aggressive forms of this disease, which do not respond well to the existing therapies. Our scientific interest is broadly in the feedback relationships between external cues and chromatin/transcription. The Team currently consists of the principal investigator, three PhD Trainees, two post-PhD researchers, and one MSc-Trainee. Our projects are structured to probe both ambitious but also more straightforward projects, which assures that my PhD Trainees graduate in 3-4 years with first author publications that enable progression to the next stage in their careers. We have expertise in both bioinformatics and molecular biology, and we are well-connected internationally. These aspects ensure that the hired PhD Trainee will have both support and also chance to present her / his findings both internally but also in international meetings. We utilize a wide range of techniques including cell biology, organoid technology, live-cell imaging, mass spectrometry, ChIP-, SLAM- and RNA-seq among others to study processes that cancer cells are addicted to (see eg. Chatterjee & al. (2026) Molecular Oncology, Gondane & al. (2025) Journal of Biomedical Science; Yalala & al (2024) FASEB, Gondane & al. (2022) Journal of Biomedical Science; Hu & al. (2021) RNA Biology, Itkonen & al. Mol Cancer Res (2020)). Our previous studies lay the foundation on future research. Radiation therapy (RT) is the cornerstone of cancer management as it is safe and effective, and it is frequently used as part of therapy against the most common cancer in men, prostate cancer. Despite being both safe and effective, in a large number of cases, it is not curative. In addition, RT comes often with significant negative side effects, and it is not understood why certain tumours respond strongly to this therapy while others fail to respond. In the current project, we use both cancer cell lines and patient-derived cancer models that incorporate the immune system. Our goal is to develop biomarkers that predict sensitivity to RT and also identify correct combinatorial therapies to augment its efficacy. In brief, we aim to turn one of the most widely used therapies to control cancer, RT, into a curative one for a large number of patients. You can find more information on our Team and projects from the laboratory’s web page: https://www.helsinki.fi/en/researchgroups/transcriptional-rewiring-cancer Your qualifications The PhD candidate must hold, or soon receive, an MSc degree, and have background in bioinformatics and / or molecular biology. Strong written and oral communication skills in English are a must. Experience in one of the following methodologies: human cell culture, RNA biology, ChIP- / RNA-sequencing is expected. Candidates are requested to familiarize themselves with the literature (see section ‘Our research’). The appointee must apply for the right to pursue a doctoral degree at the University of Helsinki within the probationary period of six months of their appointment. Please, see: www.helsinki.fi/en/research/doctoral-education/the-application-process-in-a-nutshell . The requirements for pursuing a doctoral degree at the University of Helsinki can be found at https://www.helsinki.fi/en/research/doctoral-education/eligibility-and-educational-documents . The chosen applicant is expected to reside in Finland while employed by the Universit
Kirjaudu ilmaiseksi tallentaaksesi tämän työpaikan.